UTime shares surge 22.55% after-hours on $10M smart health device deal with Tumu Vertex.

UTime Limited (NASDAQ:WTO) surged 22.55% in after-hours trading following the announcement of a $10 million procurement agreement with Denver-based Tumu Vertex LLC for 50,000 smart health devices, including blood pressure watches and ECG smart rings. The deal, marking UTime’s entry into the North American medical-grade wearable market, includes phased deliveries starting in early 2026 and joint quality control protocols. UTime’s CEO emphasized the strategic significance of the partnership, highlighting its potential to accelerate next-generation health monitoring technology development. The agreement aligns with growing demand for continuous health solutions and underscores UTime’s expansion into high-margin medical tech, bolstering investor confidence in its long-term growth prospects.